Table 2.
Characteristics of Patients by Quinolone Susceptibility
| Parameter | mMITT-S (N = 785) n (%) |
mMITT-R (N = 286) n (%) |
P Value |
|---|---|---|---|
| Age, y | <.001 | ||
| ȃMean (SD) | 50.4 (18.8) | 55.4 (19.7) | |
| ȃMin, max | 18.0, 96.0 | 18.0, 89.0 | |
| Ethnicity | <.001 | ||
| ȃHispanic or Latinx | 184 (23.4) | 111 (38.8) | |
| ȃNot Hispanic or Latinx | 598 (76.2) | 174 (60.8) | |
| ȃNot reported | 3 (0.4) | 1 (0.3) | |
| Geographic region | .091 | ||
| ȃUnited States | 406 (51.7) | 163 (57.0) | |
| ȃNot the United States | 379 (48.3) | 123 (43.0) | |
| Race | .661 | ||
| ȃBlack or African American | 67 (8.5) | 26 (9.1) | |
| ȃAsian | 6 (0.8) | 2 (0.7) | |
| ȃWhite | 706 (89.9) | 256 (89.5) | |
| ȃOther | 2 (0.3) | 2 (0.7) | |
| Diabetes mellitus | 91 (11.6) | 53 (18.5) | .004 |
| Body mass index, mean (SD), kg/m2 | 27.5 (6.6) | 28.5 (6.8) | .008 |
| Creatinine clearance,a mean (SD), mL/min | 78.4 (26.2) | 72.7 (28.2) | .001 |
Abbreviations: mMITT-R, microbiologic modified intent-to-treat with a qualifying baseline urine isolate nonsusceptible to ciprofloxacin; mMITT-S, microbiologic modified intent-to-treat with a qualifying baseline urine isolate susceptible to ciprofloxacin; SD, standard deviation.
aCalculated by Cockcroft-Gault method.